CAS: 152981-31-2 - Inolimomab
Fórmula:Unspecified
- Sinónimos:
- Inolimomab
- Immunoglobulin G1, anti-(human interleukin 2 receptor α-chain) (mouse monoclonal B-B10 γ1-chain), disulfide with mouse monoclonal B-B10 κ-chain, dimer
- Immunoglobulin G 1 (mouse monoclonal B-B10 γ-chain anti-human interleukin-2 receptor α-chain), disulfide with mouse monoclonal B-B10 κ-chain, dimer
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Inolimomab REF: TM-T77036CAS: 152981-31-2 | - - - | A consultar | Mar 29 Oct 24 |
 | Inolimomab REF: 3D-CLA1102CAS: 152981-31-2 | - - - | A consultar | Mié 06 Nov 24 |
Inolimomab
CAS:152981-31-2
Inolimomab, an anti-IL-2R α monoclonal antibody, shows promise in early aGVHD treatment studies.
Forma y color:
Solid
Ref: TM-T77036
| 5mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 29 de Octubre de 2024
Inolimomab
CAS:152981-31-2
A humanized anti-interleukin-2 receptor (IL-2R) α chain monoclonal antibody.
Ref: 3D-CLA1102
| Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Miércoles 6 de Noviembre de 2024
